Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - fexofenadine hydrochloride - oral tablet - 180mg

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v) - fexofenadine hydrochloride tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. symptoms treated effectively were sneezing, rhinorrhea, itchy nose/palate/throat, itchy/watery/red eyes. fexofenadine hydrochloride tablets are indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. it significantly reduces pruritus and the number of wheals. fexofenadine hydrochloride tablets are contraindicated in patients with known hypersensitivity to any of its ingredients.

Israel - engleză - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - film coated tablets - fexofenadine hydrochloride 120 mg - fexofenadine - relief of symptoms associated with seasonal allergic rhinitis.

Israel - engleză - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - film coated tablets - fexofenadine hydrochloride 180 mg - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria

Australia - engleză - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - fexofenadine hydrochloride, quantity: 6 mg/ml - oral liquid, suspension - excipient ingredients: xanthan gum; butyl hydroxybenzoate; propyl hydroxybenzoate; titanium dioxide; disodium edetate; purified water; monobasic sodium phosphate monohydrate; poloxamer; xylitol; propylene glycol; dibasic sodium phosphate heptahydrate; sucrose; flavour - relief of symptoms associated with seasonal allergic rhinitis and allergic rhinitis in adults and children from 2 years of age. relief of symptoms associated with urticaria in adults and children from 6 months of age.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - fexofenadine hydrochloride -

Australia - engleză - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - fexofenadine hydrochloride -

Australia - engleză - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - fexofenadine hydrochloride -

Australia - engleză - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - fexofenadine hydrochloride -

Australia - engleză - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fexofenadine hydrochloride, quantity: 180 mg - tablet, film coated - excipient ingredients: lactose; croscarmellose sodium; colloidal anhydrous silica; macrogol 400; titanium dioxide; magnesium stearate; iron oxide red; hypromellose; pregelatinised maize starch; iron oxide yellow - relief of the symptoms associated with seasonal allergic rhinitis or urticaria in adults and children 12 years or older.